(R)-Elsubrutinib free base

-Elsubrutinib-ABBV-105) is a Btk inhibitor.

For research use only. Not for human or veterinary use.

Target Btk

Research area Inflammation/Immunology Cancer

Purity >98% Stock Inquire

Data Sheet SDS COA

(R)-Elsubrutinib structure

CAS No.: 1643570-23-3

Download structure (.mol)

Pack sizes & pricing

Size	Price	SKU	Stock
10 mg	USD 450.00	BP-02408-10mg	In stock	Get quote
25 mg	USD 900.00	BP-02408-25mg	In stock	Get quote
50 mg	USD 1,440.00	BP-02408-50mg	In stock	Get quote
100 mg	USD 2,300.00	BP-02408-100mg	In stock	Get quote
250 mg	USD 4,600.00	BP-02408-250mg	In stock	Get quote
500 mg	Inquire	BP-02408-500mg	In stock	Inquire

Need another size or custom synthesis? Request a quote.

Description

(R)-Elsubrutinib ((R)-ABBV-105) is a Btk inhibitor. (R)-Elsubrutinib can be used in studies of immune diseases (such as rheumatoid arthritis, psoriasis, ankylosing spondylitis, asthma, systemic lupus erythematosus) and cancer .

Identifiers

SMILES: O=C(C1=CC=C([C@@H]2CN(C(C=C)=O)CCC2)C3=C1NC=C3)N
InChIKey: UNHZLHSLZZWMNP-NSHDSACASA-N

Specifications

MW (average): 297.3517
Formula: C₁₇H₁₉N₃O₂
CAS No.: 1643570-23-3
Physical state: Solid
Color: White to off-white
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder -20°C, 3 years , 4°C, 2 years ; In solvent -20°C, 1 month

Solubility

Soluble in DMSO : 25 mg/mL

Documents

References

[1].Dominique Bonafoux, et al. Primary carboxamides as Btk inhibitors. Patent WO2014210255Al.

Same target

Search Btk

Same research area

Search Inflammation/Immunology